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Hepatitis C virus infects almost 170 million people per year but its assembly pathway, architecture and
the structures of its envelope proteins are poorly understood. Using electron tomography of plastic-
embedded sections of insect cells, we have visualized the morphogenesis of recombinant Hepatitis C
virus-like particles. Our data provide a three-dimensional sketch of viral assembly at the endoplasmic
reticulum showing different budding stages and contiguity of buds. This latter phenomenon could play
an important role during the assembly of wt-HCV and explain the size-heterogeneity of its particles.
& 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Hepatitis C virus (HCV) is the world’s leading cause of chronic
liver disease and liver cancer (Block et al., 2003). It is an
enveloped, positive-sense ssRNA virus and unique member of
the genus Hepacivirus (Flaviviridae family). The ﬁrst 2.6 kbps of
the 9.6 kbps genome encodes the structural core protein and
the two envelope glycoproteins E1 and E2; the remaining nucleo-
tides encode the nonstructural proteins (Cocquerel et al., 2006).
After cell entry, HCV is presumed to use the endoplasmic
reticulum (ER) as the locus for replication and assembly
(Cocquerel et al., 2006; Moradpour et al., 2007). The viral budding
apparatus is constituted by the core protein that interacts with
the ER membrane and/or lipid-droplets (LDs) (Blanchard et al.,
2003; Hourioux et al., 2007; Kunkel et al., 2001; Miyanari et al.,
2007; Bartenschlager et al., 2011). The signal-peptides within the
polyprotein core–E1–E2 target E1–E2 to the ER; subsequent
cleavage by cellular signal peptidases leads to three individual
proteins (Vauloup-Fellous et al., 2006).
In vivo, circulating HCV virions are associated with lipopro-
teins and form the low-density HCV particles (Syed et al., 2010).it, Electron Microscopy Lab.,
02.
brescia).
BY-NC-ND license.While there is some two-dimensional (2D) structural informa-
tion available for HCV retro/lenti-viral pseudotype particles and
wild-type HCV (wt-HCV) (Bonnafous et al., 2010; Gastaminza
et al., 2010), the only three-dimensional (3D) structure is a low-
resolution cryo-electron microscopy reconstruction of Hepatitis C
virus-like-particles (HCV-LPs) produced in insect cells (Yu et al.,
2007). Here, icosahedral symmetry was assumed and imposed on
a subset of size-heterogeneous, puriﬁed HCV-LPs (|50 nm).
Indeed HCV-LPs produced by exploiting the self-assembling
properties of the core–E1–E2 proteins, have been proven a useful
tool for structural analysis (Baumert et al., 1998; Roingeard et al.,
2004; Yu et al., 2007) in the absence of a highly efﬁcient in-vitro
cell culture system for wt-HCV (Wakita et al., 2005). Furthermore
there is very little structural information on fundamental aspects
of the wt-HCV lifecycle such as budding and assembly. Conven-
tional 2D electron-microscopy (EM) of sections of mammalian-
cells producing HCV-LPs shows budding through the ER mem-
brane by spherical particles (Blanchard et al., 2002; Roingeard
et al., 2004) and yet a 3D description of the budding process (at
least) at the ER site is still lacking.
With this paucity of 3D information in our study we employed
electron tomography (ET) to image ﬁxed, plastic-embedded sec-
tions of insect cells infected with a recombinant baculovirus
expressing HCV structural proteins. While previous analyses of
2D cell sections have been very useful in characterizing HCV-LPs,
at the level of their localization in the cellular context and overall
D. Badia-Martinez et al. / Virology 430 (2012) 120–126 121shape (Roingeard et al., 2004, 2008), cellular ET can capture the
budding particles as free-standing objects providing advantages
over 2D EM of ultrathin sections as it adds resolution in the depth
dimension and allows 3D reconstructions.
This strategy has made it possible to view and parameterize
these objects for the ﬁrst time and each in its budding stage
of morphogenesis, from budding to scission from the ER assembly-
site.
Our results unveil the sequence of events leading the HCV-LPs
budding as surrogate for the complex wt-HCV morphogenesis at
the ER site and provide a proof-of-principle that 3D structural
work in-situ can be initiated on such a challenging system. A
better understanding of such process may open novel therapeutic
avenues aimed at inhibiting virus budding. Future structural work
should also address the involvement of LDs in the ER pathway of
assembly of wt-HCV.Results and discussion
Cellular landscape via electron-tomography
In our study, production of HCV-LPs in insect cells was clearly
visible (Fig. 1A). In contrast to control sections where the ER is
linear (Fig. 1B), sections of cells producing HCV-LPs show sphe-
rical and electron-dense structures of 50 nm size, some asso-
ciated with non-linear ER (Fig. 1C). Also, immunogold labeled
ultrathin sections show that speciﬁc regions of the ER are marked;
these are identiﬁed as the sites where HCV-LPs form (Fig. 1D and
Supplementary Fig. 1). Thus, our results show viral budding,
indicating that these HCV-LPs are not liposome-like structures
as initially hypothesized (Roingeard et al., 2004).
Recombinant expression of the HCV core–E1–E2 construct
generated an ER landscape with whorls and invaginations (Figs.
1C and 2A, left and centre) similar to that observed earlier in
mammalian cells (Blanchard et al., 2002; Egger et al., 2002). We
did not detect the formation of LDs that are thought to participate
in wt-HCV morphogenesis (Bartenschlager et al., 2011; Roingeard
et al., 2008). However it is known that variations in cellular
topography may be inﬂuenced by differences in cell-type and in
the design of the core–E1–E2 constructs used (e.g. the presence of
nonstructural proteins that might alter lipid metabolism) (Egger
et al., 2002).
Budding steps of HCV-LPs at the endoplasmic reticulum
Several tilt-series were collected, aligned and reconstructed.
From these, 11 tomograms were selected according to their
signal-to-noise ratio and information content and a total of 51
budding particles were extracted. We observed a wide variation
in the radii of curvature (12–60 nm) of the ER membranes
surrounding the bud sites. This makes it unlikely that viral
proteins create long-range order. If present, such structures are
too small to be revealed at this level of analysis. With our data
collection conditions the nominal resolution achieved is typical of
ET, between 5 and 8 nm as estimated by the formula given by
McEwen and Marko (2001). However, local ER modulation is
appreciable at the foot of the forming HCV-LPs particles where
the interplay of viral proteins and lipids promote budding.
Although it is not possible to discern ER from viral proteins, from
tomographic sections the ER appears to be moulding around the
forming particles (white-arrows in Figs. 2B and 3, bottom panels).
These particles could structurally mimic the nascent virions
before maturing into infectious Hepatitis C viruses.
Thus, to understand the HCV-LPs budding process, we ana-
lyzed the geometry of the three-dimensional buds (not theirprojections). The buds were deﬁned by their height (h), the
diameter (d) of their neck (footprint) and the radius of curvature
R between the ﬂat bilayer and the cup-shaped bud (Fig. 2A, right).
Of the 51 extracted volumes three distinctive types of particles
could be easily identiﬁed. It is reasonable to assume that these
depict different stages of budding: (i) membrane areas of protein
concentration deﬁned as ﬂat-particles (Fig. 2B, top), (ii) cup-
shaped particles (Fig. 2B, middle), and (iii) particles on the verge
of scission (Fig. 2B, bottom). Whilst ﬂat-particles have a footprint
and a height of 50.1711.5 nm and 25.479.7 nm (n¼14), respec-
tively, particles at a more advanced stage of budding (cup-
shaped) are narrower (48.178.5 nm) and taller (31.676.6 nm)
(n¼22). The radius of curvature (R) between the ER and buds
(Fig. 2A, right) ranges from 7 to 40 nm (average 21.877.7 nm;
n¼51) but the value is not necessarily invariant around each
individual bud. In the ﬁnal stage, the ﬁssion of a single HCV-LP
induces a progressive constriction, not always symmetrical
around its neck, with an average footprint of 4378.5 nm (n¼15)
(Fig. 2B, bottom). Interestingly, our observations of the budmorphol-
ogies across the different budding stages can be reproduced in a
budding dynamic simulation on a model membrane-only bilayer
patch (Hong et al., 2007) suggesting that core–E1–E2 alone could
potentially induce the pinching-off step with no aid of cellular
proteins. Biochemical and/or structural information on whether
host-proteins are involved in pinching-off from the ER membrane
for ﬂaviviruses is indeed scarce (Carpp et al., 2011). Conversely it
is recognized that other enveloped viruses, like members of
Retroviridae, Rhabdoviridae and Filoviridae families, bud from the
plasma membrane by using cellular proteins of the ESCRT com-
plex (Chen and Lamb, 2008; Welsch et al., 2007). This complex
has been implicated in production of infectious HCV particles but
not in their assembly (Ariumi et al., 2011).
In our tomograms, forming HCV-LPs appeared almost spherical
but of different sizes. Their height ranges from 25 nm to
55 nm according to budding stage (Fig. 2B, middle and bottom).
Also, a notable aspect is that in four cases we observed HCV-LPs in
a coalescent state, where two particles are contiguously budding
(Fig. 3).
It is known that both puriﬁed HCV-LPs and wt-HCV display
size variability ranging from small sized particles (30 nm) to
large ones (80 nm) although the frequency of occurrence of such
large particles is lower than particles of smaller size (Baumert
et al., 1998; Blanchard et al., 2002; Gastaminza et al., 2010; Yu
et al., 2007). Whether these variable size particles possess a regular
symmetry remains unknown. The fact that only those particles
with a speciﬁc size (55–60 nm) are infectious (Gastaminza et al.,
2010) strongly suggests that a deﬁned architecture is required for
particle infectivity.
We speculate that the size of relatively small HCV-LPs (30–
60 nm) is determined at the initial stage of assembly by the local
concentration of core–E1–E2 at the ER. This hypothesis could also be
supported (i) by the estimated limited variance of the footprint of
the ﬂat-forming particles on the membrane (/dS¼50.1711.5 nm)
(Fig. 2B, top) [probably there is a lower limit in viral protein
concentration for initial budding but ﬁnal size is tuned by variance
in concentration] and (ii) by the presence of contiguous buds (inter-
distance 55–110 nm; Fig. 3) as the result of over-accumulation of
viral proteins.
Strikingly, the coalescence of buds has also been observed
during model membrane and protein–membrane simulations
(Hong et al., 2007; Reynwar et al., 2007). This strongly suggests
that the phenomenon we have detected is not a mere incidental
occurrence. According to the latter modeling study, contiguous
particles exert attractive forces and evolve into two adjacent buds
that fuse into a larger one (Reynwar et al., 2007). This of fusion
has not previously been described for HCV and it could explain
Fig. 1. Expression and identiﬁcation of core–E1–E2 self-assembly particles. (A) Top left, immunoﬂuorescence of recombinantly expressed E2 as control of expression of the
construct core–E1–E2 in Sf9 insect cells using the AP33 as primary antibody against E2. E2 was stained with Cy3 (red) and nuclei with DAPI (blue). Top right, Western-Blot
analysis of puriﬁed HCV-LPs using the AP33 and the BDI198 antibodies against E2 and E1 proteins, respectively. Lane 1 corresponds to cells infected with the recombinant
baculovirus expressing HCV core–E1–E2 proteins and lane 2 to cells expressing GFP. Below, immunogold labeling of puriﬁed and negatively stained HCV-LPs using the
conformational CHB-2 antibody against E2. (B) Conventional 2D-microscopy of plastic-embedded mock Sf9 cells infected with baculovirus expressing GFP shows no
alteration of the ER membrane. (C) as (B) but cells infected with baculovirus expressing core–E1–E2 show convolution of the ER membrane and the presence of budding
particles (marked by arrows). Inset, forming and released HCV-LPs are seen as spherical particles. (D) Immunogold labeling of thawed cryosection of Sf9 cells expressing
core–E1–E2 using anti-E2 AP33 antibody (Tokuyasu cryo-sectioning technique). The inset highlights nanogold particles that mark convoluted regions of the ER that are the
loci for forming HCV-LPs. N¼nucleus, C¼cytoplasm, ER¼endoplasmic reticulum, NM¼nuclear membrane.
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Fig. 2. (A) Electron tomography of a Sf9 cell showing the ER landscape when expressing HCV-LPs, and segmentation of its major structural elements. Left, slice through the
center of a denoised tomogram with superimposed rendering of the convoluted ER membranes in gold, budding HCV-LPs in red and mitochondria in slate-blue. Scale-
bar¼200 nm. Center, perspective view of the outlined region. N¼nucleus, C¼cytoplasm, M¼mitochondria, ER¼endoplasmic reticulum. Right, key for the estimation of
the buds’ parameters. (B) Gallery of tomographic z sections (numbered) with below corresponding planes orthogonal to the budding direction, isosurface representation
and population statistics of the three budding major stages: ﬂat, cup-shaped and pinching-off. Top, ﬁrst step (ﬂat-stage) in particle formation, viral protein accumulation is
observed with minor bending in the ER membrane. Middle (cup-stage), glycoproteins accumulation is more evident, and a cup-like shape appears in the membrane.
Bottom (pinching stage), particle is almost formed and the particle presents an elongated shape; white arrow at section z¼80 shows the continuity of the ER with the
particle. For all isosurfaces, segmentation was carried out in Chimera (see the section ‘‘Materials and methods’’) and the boundaries between particles (red) and membrane
(gold) were assigned by eye. Scale-bars, 20 nm.
D. Badia-Martinez et al. / Virology 430 (2012) 120–126 123how very large HCV-LPs [470 nm; 6% of the total particles in
Yu et al. (2007)] and wt-HCV [470 nm; 14% of the total
particles in Gastaminza et al. (2010)] are assembled (Fig. 3). In
Gastaminza et al. (2010) different wt-HCV particles were sepa-
rated by buoyant density and related to their infectivity and size.
Particles with higher infectivity and RNA content belonged to
intermediate- and high-density particles mainly composed of two
apparently morphologically distinct particles whose size ranged
between 45 nm and 85 nm. Thus, larger particles could indeed
possess an altered ratio of viral proteins and/or genomic RNA.
Furthermore, recent studies suggest two possible sites for wt-HCV
assembly, the ER and LDs for ﬁnal production of infectious particles
and thus structural cross-talk must occur between these two
pathways (Miyanari et al., 2007; Bartenschlager et al., 2011). It is
tantalizing to hypothesize that contiguity of buds and coalescencemight be a phenomenon that is vital for virus morphogenesis (for
example in exchanging viral proteins or mediating fusion
between the virally induced LDs and the ER particle buds).
Finally, three different general mechanisms have been postu-
lated for membrane curvature: pulling, pushing and a combina-
tion of the two (Janmey and Kinnunen, 2006; Welsch et al., 2007;
Zimmerberg and Kozlov, 2006); it is reasonable to hypothesize
that a similar interplay of forces arising from the trans-membrane
regions of the core and of the E1/E2 heterodimer originate the
HCV-LPs [indeed the core alone has been shown to form pleo-
morphic vesicles (Blanchard et al., 2003; Hourioux et al., 2007)].
In conclusion, our results give the ﬁrst 3D view of the HCV-LPs
budding process and provide simpliﬁed mechanistic snapshots
and parameterization of the pathway of assembly from the
formation of small buds to ﬁssion of particles at the ER site. In
Fig. 3. Tomographic reconstruction of three different coalescent particles. Tomographic slices together with their isosurface representation and segmentation as displayed
in Fig. 2B. White arrow at section z¼62 at the bottom panel shows the continuity of the ER with the particle. Black arrows indicate the distance between coalescent
particles. Scale-bars, 20 nm.
D. Badia-Martinez et al. / Virology 430 (2012) 120–126124our view, the increasing concentration of viral core–E1–E2 mole-
cules initiates the formation of relatively small sized-particles.
Large particles could originate from coalescing buds, a property of
membrane dynamics that could also be exploited by wt-HCV
during morphogenesis.Materials and methods
Cloning of HCV-LPs
The generation of the HCV-LPs construct with core–E1–E2 poly-
protein in Sf9 insect cells followed the method described by
Baumert et al. (1998). Two differences distinguished our construct:
(i) the lack of the short stretch of the 50 UTR region preceding the
core and (ii) the use of HCV structural proteins of H77 strain
(genotype 1a). Brieﬂy, the HCV core, E1 and E2 genome regions
were ampliﬁed using primers: (forward) 50-agcctggaattcatgagcac-
gaatcctaaacc-30 and (reverse) 50-tgcgctgaagcttttagccgcctccgcttggg-30
and cloned into the pFASTBAC vector (Invitrogen).
HCV-LPs production, ﬂuorescence light-microscopy and
immuno labeling
For HCV-LPs production, Sf9 cells were infected at a multiplicity
of infection of 5–10 and 96 h post-infection were recovered for
subsequent experiments. Mock cells were infected with recombi-
nant baculovirus expressing GFP under the same conditions as thoseused for HCV-LPs production. Mock-control cells expressed GFP
under the same conditions as those used for HCV-LPs. Expression
of core–E1–E2 was conﬁrmed by immunoﬂuorescence, Western-
Blot and immunogold labeling (Fig. 1A). The antibody from the
clone BDI198 (Meridian Life Science) was used against E1 glyco-
protein whilst the AP33 (Owsianka et al., 2001) (kindly provided
by Genentech) and CBH-2/5/7 antibodies (Hadlock et al., 2000)
(gently provided by Dr. S. Foung) were used against E2 glycopro-
tein. Puriﬁcation of HCV-LPs was performed using sucrose gra-
dient according to previous protocols (Baumert et al., 1998).
Anti-mouse IgG-HRP conjugated (Sigma-Aldrich) was used as a
secondary antibody.
For ﬂuorescence experiments, insect cells were grown on a
microscope slide cover and infected at a MOI of 5–10. After 96 h
pi, cells were ﬁxed with 4% paraformaldehyde in TBS buffer. The
secondary antibodies used were Donkey anti-human Cy3 labeled
(Jackson Immunoresearch) for CBH-5 and CBH-7 and a Donkey
anti-mouse Cy3 labeled (Jackson Immunoresearch) for AP33. Cells
were visualized by immunoﬂuorescence using a Leica TCS TP
multiphoton confocal microscope. Images from Cy3 (red) and
DAPI (blue) ﬂuorescence were acquired using a 63 objective
and the Leica confocal software.
Cell preparations for electron microscopy
Infected cells were ﬁxed with 2% glutaraldehyde in PBS (pH 7.4),
stained with 1% OsO4 and processed for conventional Epon resin
embedding. Thin sections (70–200 nm) were obtained using an
D. Badia-Martinez et al. / Virology 430 (2012) 120–126 125Ultracut UCT ultramicrotome (Leica Microsystems, Germany) and a
451 diamond knife (Diatome, Switzerland), placed on 200-mesh
copper EM grids, and counterstained with uranyl acetate and lead
citrate. For immunogold labeling (Tokuyasu method), cells were
ﬁxed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4),
centrifuged, embedded in 10% gelatin, infused with 2.3 M sucrose at
4 1C overnight and frozen by immersion in liquid nitrogen. Ultrathin
cryosections (70–80 nm) were lifted using a 1:1 mixture of 2%
methylcellulose and 2.3 M sucrose, deposited on Formvar-coated
copper grids and incubated with mouse anti-E2 antibodies followed
by 15-nm Protein A-gold particles (University of Utrecht, Nether-
lands). Labeled specimens were contrasted and embedded in 0.4%
uranyl acetate in 2% methyl cellulose.
Electron microscopy and tomography
Cell sections were initially visualized by conventional EM
using a JEOL JEM 1010 (Tokyo, Japan) operating at 80 kV. Images
were recorded with a 4k4k CMOS F416 camera from TVIPS
(Gauting, Germany).
Tomographic data were collected on a JEOL JEM2200-FS with
an omega ﬁlter operated at 200kV using a single-axis tilting.
Series were collected on a 4k4k CCD camera UltrascanTM(GA-
TAN) from approximately 651 to 651, at an angle step of 1.51 or
21 with different defocus (from 5 to 7 mm) and magniﬁcations
(from 20 K to 40 K) resulting in pixel sizes at the specimen level
from 23.6 to 7.64 A˚. Sections of 70 nm and 200 nm were used and
10 nm nanogold (Sigma-Aldrich) were deposited on each side of
the grid to aid the alignment. Images were aligned and 3D
reconstructed using the weighted back-projection technique in
IMOD (Kremer et al., 1996) or alternatively 3D reconstructed by
SIRT (Agulleiro and Fernandez, 2011).
Analysis and segmentation
Post-processing analyses used AMIRA and Chimera (Pettersen
et al., 2004). Tomograms were ﬁltered with either a Gaussian
ﬁlter (1s and kernel of 5) in AMIRA or TOMOBFLOW (1s, 100–150
iterations) (Fernandez, 2009) and analyzed at different threshold
levels for consistency of features. Estimations of the bud para-
meters (d, h) were made by placing a sphere of known radius at
the footprint of the bud (d) and by increasing its radius to match
the height of the bud (h) whilst the curvature radii (R)
(Zimmerberg and Kozlov, 2006) was assessed by putting a sphere
of known radius around the bud (Fig. 2A, right). Initial segmenta-
tion was carried out using highly denoised tomograms as a mask
to discriminate between ultracellular features and background
then segmentation of the individual budding particles from ER
membrane was performed using the watershed algorithm of the
‘Segger’ tool (Pintilie et al., 2010) in Chimera and by user assign-
ment of the relative boundaries.Acknowledgments
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